HHS handling of Provider Relief Fund distributions ‘alarming,’ Argentum says
By
Kathleen Steele Gaivin
Oct 13, 2022
The results of a congressionally mandated audit by the Health and Human Services Office of Inspector General of Provider Relief Fund distributions are “alarming”
Study IDs proportion of dementia cases attributable to known risk factors
Jan 19, 2024
The population-attributable fraction for nongenetic risk factors combined is similar for men and women, but it varies across racial and ethnic groups.
Risk for incident dementia increased with diagnosed depression
Jul 24, 2023
An increased risk was seen when the time from the index date was longer than 20 to 39 years and for diagnosis of depression in early, middle or late life.
MIND diet plus caloric restriction no better for cognition
Jul 19, 2023
A small improvement seen in global cognition scores, but it was no different from those following control diet with mild caloric restriction.
Higher, lower HDL cholesterol linked to increased risk for dementia
Oct 04, 2023
An increased risk for Alzheimer’s disease and related dementia was seen in association with higher and lower versus middle quintile of HDL-C.
Higher olive oil intake tied to lower risk for dementia-related death
May 08, 2024
The findings were seen among US adults irrespective of overall diet quality.
Two-thirds of survivors of the most severe COVID-19 face impairment at one year
Apr 26, 2024
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
Burnout, poor staffing substantially contribute to nurses leaving healthcare
Apr 11, 2024
The authors say that the leading reasons nurses leave healthcare signal opportunities for employers to reattract an existing nurse workforce.
Social isolation tied to higher dementia risk
Jan 11, 2023
The risk was found to be similar across racial and ethnic groups of older adults in the United States.
5α-reductase inhibitors linked to depression, but not dementia
Dec 29, 2022
The magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant.